Artwork for podcast HemaSphere Podcast
Inequalities in sickle cell therapies - Ep 4.1
Episode 1 • 2nd December 2025 • HemaSphere Podcast • HemaSphere Journal
00:00:00 00:55:14

Share Episode

Shownotes

In this extended episode of the HemaSphere podcast, based on a must-read Perspective "Can health inequalities in sickle cell disease be addressed through novel therapies?", our host Scientific Editor Charles de Bock discusses sickle cell disease with co-authors, covering both expert and lived-patient perspectives. They explore the complexities of living with the disease, the current treatment landscape, and highlight the ongoing health inequalities faced by patients, the impact of withdrawn therapies, and the need for improved communication and trust between patients and healthcare providers.

Further information:

No One's Listening Report

Shaniqua's Sickle Chronicles

NICE (National Institute for Health and Care Excellence)

UK NHS blood donation

Please take a few minutes and let us know what you think about this episode! Podcast Feedback


Links

Chapters

Video

More from YouTube

More Episodes
1. Inequalities in sickle cell therapies - Ep 4.1
00:55:14
8. Defining Lineage in Ambiguous Leukemia: A Transcriptomic View Ep 3.7
00:35:42
7. EHA/EBMT Survey on Grading and Management of ICAHT - Ep 3.7
00:40:58
6. Tackling NUP98 Rearranged AML in Pediatric Oncology - Ep 3.5
00:41:07
5. Part 2 - Metabolism in hematology - Ep 3.4
00:28:52
4. Part 1 - Metabolism in hematology - Ep 3.4
00:29:51
3. Machine learning for AML-MRD - Ep 3.3
00:29:23
2. 2 of 2: Navigating Neutropenia: New Guidelines Explained - Ep 3.2
00:28:05
1. Single‐cell DNA and surface protein - Ep 3.1
00:34:16
8. Two distinct fetal-type signatures characterize JMML - Ep 2.8
00:36:59
7. Revolutionizing Pediatric Cancer Research with PDXs - Ep 2.7
00:35:54
6. High 5hmC predicts worse OS - Ep 2.6
00:25:14
5. Informed consent is almost impossible - Ep 2.5
00:39:11
4. Best of Pediatric Hematology from EHA2024 - Ep 2.4
00:42:23
3. NOTCH1 fusions in T‐LBL - Ep 2.3
00:23:34
2. A transcriptional cofactor‐mediated dependency module - Ep 2.2
00:24:47
1. Unraveling the secrets of thrombopoiesis - Ep 2.1
00:25:20
10. What’s so Great About the P-value? A Statistician’s Point of View - Ep 1.8
00:30:23
9. This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies - Ep 1.7
00:24:15
6. 1 of 2: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children - Ep 1.6
00:27:28
4. Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.4
00:23:23
5. Part 2 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.5
00:24:32
3. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis - Ep 1.3
00:34:01
2. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer - Ep 1.2
00:24:32
1. Long COVID-19” of Researchers: What to Do Next? - Ep 1.1
00:20:06